G. Gustafson

发表

System for prostate brachytherapy and biopsy in a standard 1.5 T MRI scanner

C. N. Coleman, C. Coleman, R. C. Susil, 2004, Magnetic resonance in medicine.

MRI-guided HDR prostate brachytherapy in standard 1.5T scanner.

C. N. Coleman, J. Pouliot, C. Coleman, 2004, International journal of radiation oncology, biology, physics.

A new model using number of needles and androgen deprivation to predict chronic urinary toxicity for high or low dose rate prostate brachytherapy.

G. Gustafson, Alvaro Martinez, C. Vargas, 2005, The Journal of urology.

A comprehensive review of prostate cancer brachytherapy: defining an optimal technique.

G. Gustafson, F. Vicini, A. Martinez, 1999, International journal of radiation oncology, biology, physics.

Phase II prospective study of the use of conformal high-dose-rate brachytherapy as monotherapy for the treatment of favorable stage prostate cancer: a feasibility report.

G. Gustafson, A. Martinez, G. Edmundson, 2001, International journal of radiation oncology, biology, physics.

Predictors for chronic urinary toxicity after the treatment of prostate cancer with adaptive three-dimensional conformal radiotherapy: dose-volume analysis of a phase II dose-escalation study.

G. Gustafson, D. Yan, F. Vicini, 2007, International journal of radiation oncology, biology, physics.

EXTERNAL BEAM RADIATION THERAPY TREATMENT PLANNING FOR CLINICALLY LOCALIZED PROSTATE CANCER on Radiation Oncology–Prostate:

A. D'Amico, G. Gustafson, G. Ezzell, 2016 .

The impact of temporary iodine‐125 interstitial implant boost in the primary management of squamous cell carcinoma of the oropharynx

G. Gustafson, F. Vicini, G. Edmundson, 1997, Head & neck.

ACR Appropriateness Criteria® external beam radiation therapy treatment planning for clinically localized prostate cancer, part I of II

A. D'Amico, G. Gustafson, G. Ezzell, 2016, Advances in radiation oncology.

Comparison of dose-escalated, image-guided radiotherapy vs. dose-escalated, high-dose-rate brachytherapy boost in a modern cohort of intermediate-risk prostate cancer patients.

G. Gustafson, D. Brabbins, L. Kestin, 2014, Brachytherapy.

Lack of benefit from a short course of androgen deprivation for unfavorable prostate cancer patients treated with an accelerated hypofractionated regime.

G. Gustafson, C. Vargas, Jose A Gonzalez, 2005, International journal of radiation oncology, biology, physics.

Long-term results of full-dose gemcitabine with radiation therapy compared to 5-fluorouracil with radiation therapy for locally advanced pancreas cancer.

G. Gustafson, J. Robertson, S. Balaraman, 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Low-dose-rate brachytherapy as the sole radiation modality in the management of patients with early-stage breast cancer treated with breast-conserving therapy: preliminary results of a pilot trial.

G. Gustafson, F. Vicini, A. Martinez, 1997, International journal of radiation oncology, biology, physics.

Matched-Pair Analysis of Prostate Cancer Patients With a High Risk of Positive Pelvic Lymph Nodes Treated With and Without Pelvic RT and High-Dose Radiation Using High Dose Rate Brachytherapy

G. Gustafson, C. Vargas, Jose A Gonzalez, 2006, American journal of clinical oncology.

Accelerated partial breast irradiation via interstitial brachytherapy as the sole radiation modality for treatment of early-stage breast cancer

G. Gustafson, F. Vicini, Peter Y. Chen, 2002 .

Long-term outcome with interstitial brachytherapy in the management of patients with early-stage breast cancer treated with breast-conserving therapy.

D. M. Brown, G. Gustafson, F. Vicini, 1997, International journal of radiation oncology, biology, physics.

Abstract GS4-04: Primary results of NSABP B-39/RTOG 0413 (NRG Oncology): A randomized phase III study of conventional whole breast irradiation (WBI) versus partial breast irradiation (PBI) for women with stage 0, I, or II breast cancer

W. Curran, M. Scheier, G. Gustafson, 2019, General Session Abstracts.

G. Gustafson, Alvaro Martinez, L. Kestin, 2005 .

Surgical considerations in the treatment of early stage breast cancer with accelerated partial breast irradiation (APBI) in breast conserving therapy via intersitial brachytherapy

G. Gustafson, F. Vicini, G. Edmundson, 2004 .

Three-year Clinical Experience Utilizing 3D-Conformal Radiation Therapy to Deliver Accelerated Partial Breast Irradiation (APBI)

G. Gustafson, F. Vicini, Peter Y. Chen, 2008 .

PSA bounce after prostate brachytherapy with or without neoadjuvant androgen deprivation.

G. Gustafson, F. Vicini, L. Kestin, 2010, Brachytherapy.

Cost-effectiveness of prostate boost with high-dose-rate brachytherapy versus intensity-modulated radiation therapy in the treatment of intermediate-high risk prostate cancer.

G. Gustafson, D. Krauss, C. Vu, 2017, Brachytherapy.

DEFINITIVE EXTERNAL-BEAM IRRADIATION IN STAGE T1 AND T2 PROSTATE CANCER

A. D'Amico, Y. Yamada, G. Gustafson, 2013 .

Pathologic evidence of dose-response and dose-volume relationships for prostate cancer treated with combined external beam radiotherapy and high-dose-rate brachytherapy.

G. Gustafson, F. Vicini, L. Kestin, 2002, International journal of radiation oncology, biology, physics.

Lack of benefit for the addition of androgen deprivation therapy to dose-escalated radiotherapy in the treatment of intermediate- and high-risk prostate cancer.

G. Gustafson, F. Vicini, Alvaro Martinez, 2008, International journal of radiation oncology, biology, physics.

Comparison of acute and late toxicities for three modern high-dose radiation treatment techniques for localized prostate cancer.

G. Gustafson, F. Vicini, D. Brabbins, 2012, International journal of radiation oncology, biology, physics.

Dose escalation using conformal high-dose-rate brachytherapy improves outcome in unfavorable prostate cancer.

Chris Mitchell, G. Gustafson, F. Vicini, 2002, International Journal of Radiation Oncology, Biology, Physics.

Matched-pair analysis of conformal high-dose-rate brachytherapy boost versus external-beam radiation therapy alone for locally advanced prostate cancer.

G. Gustafson, F. Vicini, A. Martinez, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Interim report of image-guided conformal high-dose-rate brachytherapy for patients with unfavorable prostate cancer: the William Beaumont phase II dose-escalating trial.

G. Gustafson, F. Vicini, A. Martinez, 2000, International journal of radiation oncology, biology, physics.

Matched-Pair A nalysis o f C onformal H igh-Dose-Rate Brachytherapy B oost V ersus E xternal-Beam R adiation Therapy A lone f or L ocally A dvanced P rostate C ancer

G. Gustafson, F. Vicini, G. Edmundson, 2000 .

Excellent functional outcome in patients with squamous cell carcinoma of the base of tongue treated with external irradiation and interstitial iodine 125 boost

G. Gustafson, F. Vicini, A. Martinez, 1996, Cancer.

An age-corrected matched-pair study of erectile function in patients treated with dose-escalated adaptive image-guided intensity-modulated radiation therapy vs. high-dose-rate brachytherapy for prostate cancer.

G. Gustafson, D. Brabbins, I. Grills, 2014, Brachytherapy.

Quality of Life Implications of Dose-Escalated External Beam Radiation for Localized Prostate Cancer: Results of a Prospective Randomized Phase 3 Clinical Trial, NRG/RTOG 0126.

G. Gustafson, H. Sandler, M. Lock, 2022, International journal of radiation oncology, biology, physics.

Dose-volume analysis of predictors for chronic rectal toxicity after treatment of prostate cancer with adaptive image-guided radiotherapy.

G. Gustafson, D. Yan, F. Vicini, 2005, International journal of radiation oncology, biology, physics.

Rates of rectal toxicity in patients treated with high dose rate brachytherapy as monotherapy compared to dose-escalated external beam radiation therapy for localized prostate cancer.

G. Gustafson, D. Yan, M. Ghilezan, 2020, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Long-term outcome by risk factors using conformal high-dose-rate brachytherapy (HDR-BT) boost with or without neoadjuvant androgen suppression for localized prostate cancer.

T. Mate, G. Gustafson, G. Edmundson, 2004, International journal of radiation oncology, biology, physics.

High dose rate brachytherapy in the treatment of prostate cancer

G. Gustafson, F. Vicini, G. Edmundson, 2003, World Journal of Urology.

Five-Year Outcomes of a Single-Institution Prospective Trial of 19-Gy Single-Fraction High-Dose-Rate Brachytherapy for Low- and Intermediate-Risk Prostate Cancer.

Zaid A. Siddiqui, G. Gustafson, E. Sebastian, 2018, International journal of radiation oncology, biology, physics.

High-Dose-Rate Prostate Brachytherapy: An Excellent Accelerated-Hypofractionated Treatment for Favorable Prostate Cancer

G. Gustafson, C. Vargas, M. Ghilezan, 2010, American journal of clinical oncology.

High-dose-rate brachytherapy as monotherapy delivered in two fractions over one day for favorable-risk prostate cancer. Preliminary toxicity data

G. Gustafson, M. Ghilezan, E. Sebastian, 2009 .

High Dose Rate Brachytherapy (HDR-BT) as Monotherapy for Favorable Prostate Cancer: Excellent 5-Year Control Rates and Low Toxicity

G. Gustafson, I. Bernstein, L. Schour, 2007 .

High dose rate brachytherapy as prostate cancer monotherapy reduces toxicity compared to low dose rate palladium seeds.

G. Gustafson, I. Grills, Peter Y. Chen, 2004, The Journal of urology.

Conformal high dose rate brachytherapy improves biochemical control and cause specific survival in patients with prostate cancer and poor prognostic factors.

G. Gustafson, F. Vicini, L. Kestin, 2003, The Journal of urology.

ACR Appropriateness Criteria high-dose-rate brachytherapy for prostate cancer.

A. D'Amico, Y. Yamada, G. Gustafson, 2014, Brachytherapy.

Brachytherapy provides comparable outcomes and improved cost-effectiveness in the treatment of low/intermediate prostate cancer.

G. Gustafson, F. Vicini, H. Ye, 2012, Brachytherapy.

ACR Appropriateness Criteria for external beam radiation therapy treatment planning for clinically localized prostate cancer, part II of II

Benjamin Movsas, Timothy N. Showalter, Anthony V. D'Amico, 2017, Advances in radiation oncology.

Use of three-dimensional radiation therapy planning tools and intraoperative ultrasound to evaluate high dose rate prostate brachytherapy implants.

G. Gustafson, F. Vicini, A. Martinez, 1999, International journal of radiation oncology, biology, physics.

Normal Tissue Integral Dose as a Result of Prostate Radiation Therapy: A Quantitative Comparison Between High-Dose-Rate Brachytherapy and Modern External Beam Radiation Therapy Techniques

G. Gustafson, J. Hafron, E. Sebastian, 2022, Advances in radiation oncology.

Prognostic significance of neuroendocrine differentiation in patients with Gleason score 8-10 prostate cancer treated with primary radiotherapy.

G. Gustafson, F. Vicini, D. Brabbins, 2011, International journal of radiation oncology, biology, physics.

Treatment planning comparison of IMPT, VMAT and 4π radiotherapy for prostate cases

Ke Sheng, Dan Nguyen, Victoria Yu, 2017, Radiation oncology.

Cosmetic Outcome from Post Lumpectomy Whole Breast Irradiation (WBI) Versus Partial Breast Irradiation (PBI) on the NRG Oncology/NSABP B39-RTOG 0413 Phase III Clinical Trial

G. Gustafson, T. Julian, F. Vicini, 2019, International Journal of Radiation Oncology*Biology*Physics.

111 Mammographically detected DCIS treated with breast conserving therapy: An analysis of clinical, pathologic, and treatment related factors affecting outcome

G. Gustafson, F. Vicini, E. Horwitz, 1996 .

ACR Appropriateness Criteria® Locally Advanced, High-Risk Prostate Cancer

A. D'Amico, G. Gustafson, P. McLaughlin, 2017, American journal of clinical oncology.

ACR appropriateness criteria: Permanent source brachytherapy for prostate cancer.

A. D'Amico, G. Gustafson, P. McLaughlin, 2017, Brachytherapy.

PERMANENT SOURCE BRACHYTHERAPY FOR PROSTATE CANCER

A. D'Amico, G. Gustafson, P. McLaughlin, 2016 .

Conformal high dose rate iridium-192 boost brachytherapy in locally advanced prostate cancer: superior prostate-specific antigen response compared with external beam treatment.

G. Gustafson, F. Vicini, A. Martinez, 1997, The cancer journal from Scientific American.

Increasing Fractional Doses Increases the Probability of Benign PSA Bounce in Patients Undergoing Definitive HDR Brachytherapy for Prostate Cancer.

G. Gustafson, H. Ye, Peter Y. Chen, 2017, International journal of radiation oncology, biology, physics.

An Internet-ready database for prospective randomized clinical trials of high-dose-rate brachytherapy for adenocarcinoma of the prostate.

T. Mate, G. Gustafson, S. Nag, 2002, International journal of radiation oncology, biology, physics.

Long-term results of NRG Oncology/RTOG 0321 a phase II trial of combined high dose rate brachytherapy and external beam radiotherapy for adenocarcinoma of the prostate.

I. Hsu, G. Gustafson, H. Sandler, 2019, International journal of radiation oncology, biology, physics.

A dose-escalation trial with the adaptive radiotherapy process as a delivery system in localized prostate cancer: analysis of chronic toxicity.

John Wong, Di Yan, David Lockman, 2005, International journal of radiation oncology, biology, physics.

Favorable Preliminary Outcomes for Men With Low- and Intermediate-risk Prostate Cancer Treated With 19-Gy Single-fraction High-dose-rate Brachytherapy.

G. Gustafson, E. Sebastian, H. Ye, 2017, International journal of radiation oncology, biology, physics.

High-dose-rate monotherapy: safe and effective brachytherapy for patients with localized prostate cancer.

G. Gustafson, M. Ghilezan, L. Schour, 2011, International journal of radiation oncology, biology, physics.

EXTERNAL BEAM RADIATION THERAPY TREATMENT PLANNING FOR CLINICALLY LOCALIZED PROSTATE CANCER

A. D'Amico, G. Gustafson, G. Ezzell, 2016 .

Outcomes and toxicity from a prospective study of moderately hypofractionated radiation therapy for prostate cancer

Wei Gang Wang, G. Gustafson, D. Yan, 2017, Advances in radiation oncology.

Response to Drs Rogers, Hayes, and Demanes.

A. D'Amico, Y. Yamada, G. Gustafson, 2014, Brachytherapy.

A Modified Phoenix Biochemical Failure (BF) Definition to Account for PSA Bounce Phenomenon for Prostate Cancer Patients Treated with Brachytherapy (BT)

Sean S. Park, G. Gustafson, F. Vicini, 2009 .

Outcomes Associated With 3 Treatment Schedules of High-Dose-Rate Brachytherapy Monotherapy for Favorable-Risk Prostate Cancer.

Hong Ye, G. Gustafson, H. Ye, 2016, International journal of radiation oncology, biology, physics.

10-year Results in 1577 Intermediate/High Risk Prostate Cancer Patients Treated With External Beam RT (EBRT) and Hypofractionated High Dose Rate (HDR) Brachytherapy Boost

G. Gustafson, Alvaro Martinez, R. Galalae, 2007 .

High-dose irradiation for prostate cancer via a high-dose-rate brachytherapy boost: results of a phase I to II study.

Neal Goldstein, G. Gustafson, C. Vargas, 2006, International journal of radiation oncology, biology, physics.

Dose escalation in prostate cancer: a comparison of RTOG chronic toxicities for patients treated in the adaptive external beam process with 3D-conformal or IMRT vs. external beam plus conformal HDR brachytherapy boost

G. Gustafson, D. Yan, F. Vicini, 2002 .

Predictors for chronic urinary toxicity following treatment of prostate cancer with 3-d conformal radiotherapy: Dose-volume analysis of a phase II dose escalation study

G. Gustafson, D. Yan, F. Vicini, 2004 .

HIGH-DOSE-RATE BRACHYTHERAPY FOR PROSTATE CANCER Expert Panel on Radiation Oncology–Prostate

Y. Yamada, G. Gustafson, S. Frank, 2013 .

Treatment planning comparison of IMPT, VMAT and 4π radiotherapy for prostate cases

Ke Sheng, G. Gustafson, K. Sheng, 2017, Radiation Oncology.

ACR appropriateness Criteria® Postradical prostatectomy irradiation in prostate cancer.

A. D'Amico, Y. Yamada, G. Gustafson, 2014, Oncology.

High dose rate brachytherapy in the treatment of prostate cancer

G. Gustafson, F. Vicini, G. Edmundson, 2003 .

Iridium-192 transperineal interstitial brachytherapy for locally advanced or recurrent gynecological malignancies.

G. Gustafson, F. Vicini, A. Martinez, 1999, International journal of radiation oncology, biology, physics.

Dose-Escalated Radiation Alone or in Combination With Short-Term Total Androgen Suppression for Intermediate-Risk Prostate Cancer: Patient-Reported Outcomes From NRG/Radiation Therapy Oncology Group 0815 Randomized Trial

G. Gustafson, D. Yan, H. Sandler, 2023, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

ACR Appropriateness Criteria® Definitive External-Beam Irradiation in Stage T1 and T2 Prostate Cancer

A. D'Amico, Y. Yamada, G. Gustafson, 2011, American journal of clinical oncology.

Conformal prostate brachytherapy: initial experience of a phase I/II dose-escalating trial.

G. Gustafson, D. Yan, F. Vicini, 1995, International journal of radiation oncology, biology, physics.

EXTERNAL BEAM RADIATION THERAPY TREATMENT PLANNING FOR CLINICALLY LOCALIZED PROSTATE CANCER on Radiation Oncology–Prostate:

A. D'Amico, G. Gustafson, G. Ezzell, 2016 .

HDR vs. LDR (Pd103 permanent implants) brachytherapy as monotherapy for prostate cancer. timing to onset and predictors of erectile dysfunction

G. Gustafson, G. Edmundson, D. Brabbins, 2004 .

ACR appropriateness criteria: Permanent source brachytherapy for prostate cancer.

A. D'Amico, G. Gustafson, D. Assimos, 2017, Brachytherapy.

137 The effects of androgen deprivation on patients with locally advanced prostate cancer treatment with external beam radiotherapy plus conformal high dose rate brachytherapy boost

G. Gustafson, F. Vicini, G. Edmundson, 2000 .

Ultrasound-guided high dose rate conformal brachytherapy boost in prostate cancer: treatment description and preliminary results of a phase I/II clinical trial.

G. Gustafson, F. Vicini, A. Martinez, 1995, International journal of radiation oncology, biology, physics.

116 Overcoming internal prostatic motion and set-up inaccuracies with conformal interstitial brachytherapy

G. Gustafson, D. Yan, F. Vicini, 1995 .

Association of Postmastectomy Radiation Therapy with Overall Survival for Women with pT3N0 Breast Cancer: An NCDB Analysis

Zaid A. Siddiqui, G. Gustafson, M. Almahariq, 2019, International Journal of Radiation Oncology*Biology*Physics.

10 Year Radiotherapy Results for Prostate Cancer Patients Harboring Gleason 7-10, Stage ≥T2b, iPSA ≥20: More and Faster is Better

G. Gustafson, F. Vicini, D. Brabbins, 2008 .